American Journal of Preventive Medicine
Volume 36, Issue 2 , Pages 96-104.e1 , February 2009

Quitting by Gradual Smoking Reduction Using Nicotine Gum: A Randomized Controlled Trial

  • Saul Shiffman, PhD

      Affiliations

    • Pinney Associates, Inc., and the University of Pittsburgh, Pittsburgh, Pennsylvania
    • Corresponding Author InformationAddress correspondence and reprint requests to: Saul Shiffman, PhD, Pinney Associates, 201 North Craig Street, Suite 320, Pittsburgh PA 15213
    • ,
  • Stuart G. Ferguson, PhD

      Affiliations

    • Pinney Associates, Inc., and the University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Kenneth R. Strahs, PhD

      Affiliations

    • GlaxoSmithKline Consumer Healthcare, Parsippany, New Jersey

References 

  1. Peto R. Smoking and death: the past 40 years and the next 40. BMJ. 1994;309:937–939
  2. CDC. Cigarette smoking among adults—United States, 2000. MMWR. 2002;51:642–645
  3. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008;34:102–111
  4. Fiore MC. Treating tobacco use and dependence: an introduction to the U.S. Public Health Service Clinical Practice Guideline. Respir Care. 2000;45:1196–1199
  5. Garvey AJ, Bliss RE, Hitchcock JL, Heinold JW, Rosner B. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict Behav. 1992;17:367–377
  6. Hughes JR, Gulliver SB, Fenwick JW, et al. Smoking cessation among self-quitters. Health Psychol. 1992;11:331–334
  7. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;(3):CD000146
  8. Hughes JR, Callas PW, Peters EN. Interest in gradual cessation. Nicotine Tob Res. 2007;9:671–675
  9. Shiffman S, Hughes JR, Ferguson SG, Pillitteri JL, Gitchell JG, Burton SL. Smokers' interest in using nicotine replacement to aid smoking reduction. Nicotine Tob Res. 2007;9:1177–1182
  10. Cheong Y, Yong HH, Borland R. Does how you quit affect success? (A comparison between abrupt and gradual methods using data from the International Tobacco Control Policy Evaluation Study). Nicotine Tob Res. 2007;9:801–810
  11. Peters EN, Hughes JR, Callas PW, Solomon LJ. Goals indicate motivation to quit smoking. Addiction. 2007;102:1158–1163
  12. Shiffman S, Gitchell J, Pinney JM, Burton SL, Kemper KE, Lara EA. Public health benefit of over-the-counter nicotine medications. Tob Control. 1997;6:306–310
  13. Rose JE, Behm FM. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob Res. 2004;6:523–532
  14. Carpenter MJ, Hughes JR, Keely JP. Effect of smoking reduction on later cessation: a pilot experimental study. Nicotine Tob Res. 2003;5:155–162
  15. Cinciripini PM, Lapitsky LG, Wallfisch A, Mace R, Nezami E, Van Vunakis H. An evaluation of a multicomponent treatment program involving scheduled smoking and relapse prevention procedures: initial findings. Addict Behav. 1994;19:13–22
  16. Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Kitchens K, Van Vunakis H. The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal?. J Consult Clin Psychol. 1995;63:388–399
  17. Levinson BL, Shapiro D, Schwartz GE, Tursky B. Smoking elimination by gradual reduction. Behavior Therapy. 1971;2:477–487
  18. West R, Shiffman S. Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacology (Berl). 2001;155:115–122
  19. Shiffman S, Ferguson SG, Gwaltney CJ, Balabanis MH, Shadel WG. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy. Psychopharmacology (Berl). 2006;184:637–644
  20. Cooper T, Clayton R. New hope for heavy smokers: the cooper/clayton method for stop smoking. Lexington: SBC Publishers; 1988;
  21. Hughes JR, Carpenter MJ. The feasibility of smoking reduction: an update. Addiction. 2005;100:1074–1089
  22. Fagerstrom KO. Can reduced smoking be a way for smokers not interested in quitting to actually quit?. Respiration. 2005;72:216–220
  23. Committee on Safety of Medicines and Healthcare Products Regulatory Agency (CSMHPRA). Report of the committee on safety of medicines working group on nicotine replacement therapy 2006. London, CSM & MHRSA. www.mhra.gov.uk.
  24. Brown R, Burgess E, Sales S, Whitely J, Evans D, Miller I. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav. 1998;12:101–112
  25. Shields PG. Tobacco smoking, harm reduction, and biomarkers. J Natl Cancer Inst. 2002;94:1435–1444
  26. Benowitz NL, Kuyt F, Jacob P. Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther. 1982;32:758–764
  27. Junge B. Changes in serum thiocyanate concentration on stopping smoking. Br Med J (Clin Res Ed). 1985;291:22
  28. U.S. Food and Drug Administration. Transcript of the Joint Meeting of the Non-prescription Drugs Advisory Committee and the Drug Abuse Advisory Committee of the Food and Drug Administration.
  29. Shiffman S, Rolf CN, Hellebusch SJ, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction. 2002;97:505–516
  30. Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D. Cut down to quit with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess. 2008;12:iii–iv, ix–xi, 1–135
  31. Hammond D, Fong GT, Cummings KM, Hyland A. Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev. 2005;14:1370–1375
  32. Schwartz JL. Review and evaluation of smoking cessation methods: the United States and Canada, 1978–1985. Washington DC: U.S. Government Printing Office; 1987;
  33. Shiffman S, Scharf DM, Shadel WG, et al. Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol. 2006;74:276–285
  34. Shiffman S. Use of more nicotine lozenges leads to better success in quitting smoking. Addiction. 2007;102:809–814
  35. Abrams DB, Niaura R, Brown RA, Emmons KM, Goldstein MG, Monti PM. Tobacco dependence treatment handbook: a guide to best practices. New York: Guilford Press; 2003;
  36. Shiffman S, Paty JA, Rohay JM, Di Marino ME, Gitchell J. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine polacrilex gum therapy. Arch Intern Med. 2000;160:1675–1681
  37. Nemeth-Coslett R, Henningfield JE. Effects of nicotine chewing gum on cigarette smoking and subjective and physiologic effects. Clin Pharmacol Ther. 1986;39:625–630
  38. Murray RP, Bailey WC, Daniels K, et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study (Lung Health Study Research Group). Chest. 1996;109:438–445
  39. Mahmarian JJ, Moye LA, Nasser GA, et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol. 1997;30:125–130

PII: S0749-3797(08)00891-X

doi: 10.1016/j.amepre.2008.09.039

American Journal of Preventive Medicine
Volume 36, Issue 2 , Pages 96-104.e1 , February 2009

Article Tools

* Image Usage & Resolution